Cancer Institute A national cancer institute
designated cancer center

Michael Link

Publication Details

  • Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.

    Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS. J Clin Oncol. 2003; 21 (10): 2026-33

    Evaluation of pretreatment factors to identify children at high risk for relapse after combined-modality therapy for Hodgkin's disease.

    PubMedID: 12743158

Stanford Medicine Resources:

Footer Links: